The DOI matches its Crossref record; 274 of the 274 references it cites were found in a registry or an index.
Successful oral delivery of poorly water-soluble drugs both depends on the intraluminal behavior of drugs and of appropriate advanced drug delivery systems
Open accessAbstract
Poorly water-soluble drugs continue to be a problematic, yet important class of pharmaceutical compounds for treatment of a wide range of diseases. Their prevalence in discovery is still high, and their development is usually limited by our lack of a complete understanding of how the complex chemical, physiological and biochemical processes that occur between administration and absorption individually and together impact on bioavailability. This review defines the challenge presented by these drugs, outlines contemporary strategies to solve this challenge, and consequent in silico and in vitro evaluation of the delivery technologies for poorly water-soluble drugs. The next steps and unmet needs are proposed to present a roadmap for future studies for the field to consider enabling progress in delivery of poorly water-soluble compounds.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ng, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., Mullany, E. C., Biryukov, S., Abbafati, C., Abera, S. F., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60460-8 · Cited by 11,952
Molecular properties that influence the oral bioavailability of drug candidates
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020017n · Cited by 8,420
A standardised static in vitro digestion method suitable for food – an international consensus
Minekus, M., Alminger, M., Alvito, P., Ballance, S., Bohn, T., Bourlieu, C., Carrière, F., Boutrou, R., Corredig, M., Dupont, D., et al. (2014) · Food Funct. · doi:10.1039/c3fo60702j · Cited by 5,824
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430
Surfactants and interfacial phenomena
(2005) · Choice Reviews Online · doi:10.5860/choice.42-2832 · Cited by 5,395
INFOGEST static in vitro simulation of gastrointestinal food digestion
Brodkorb, A., Egger, L., Alminger, M., Alvito, P., Assunção, R., Ballance, S., Bohn, T., Bourlieu-Lacanal, C., Boutrou, R., Carrière, F., et al. (2019) · Nature Protocols · doi:10.1038/s41596-018-0119-1 · Cited by 5,199
Methods of Digital Video Microscopy for Colloidal Studies
Crocker, J. C., & Grier, D. G. (1996) · Journal of Colloid and Interface Science · doi:10.1006/jcis.1996.0217 · Cited by 3,765
Surfactants and Interfacial Phenomena
Rosen, M. J. (2004) · Wiley eBooks · doi:10.1002/0471670561 · Cited by 2,966
The influence of drug-like concepts on decision-making in medicinal chemistry
Leeson, P. D., & Springthorpe, B. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2445 · Cited by 2,403
Lipids and Lipid-Based Formulations: Optimizing the Oral Delivery of Lipophilic Drugs
Porter, C. J. H., Trevaskis, N. L., & Charman, W. N. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2197 · Cited by 1,824
Artursson, P., Palm, K., & Luthman, K. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00128-9 · Cited by 1,543
Salt formation to improve drug solubility
Serajuddin, A. T. M. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.010 · Cited by 1,425
Amorphous pharmaceutical solids: preparation, characterization and stabilization
Yu, L. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00098-9 · Cited by 1,405
Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach
des Rieux, A., Fievez, V., Garinot, M., Schneider, Y.-J., & Préat, V. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.08.013 · Cited by 1,305
Pouton, C. W. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.04.016 · Cited by 1,293
Tackling Exascale Software Challenges in Molecular Dynamics Simulations with GROMACS
Páll, S., Abraham, M. J., Kutzner, C., Hess, B., & Lindahl, E. (2015) · Lecture Notes in Computer Science · doi:10.1007/978-3-319-15976-8_1 · Cited by 1,208
Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Immediate Release Dosage Forms
Dressman, J. B., Amidon, G. L., Reppas, C., & Shah, V. P. (1998) · Pharmaceutical Research · doi:10.1023/a:1011984216775 · Cited by 1,097
Simulated Biological Fluids with Possible Application in Dissolution Testing
Marques, M. R. C., Loebenberg, R., & Almukainzi, M. (2011) · Dissolution Technologies · doi:10.14227/dt180311p15 · Cited by 1,073
MDCK (Madin-Darby Canine Kidney) Cells: A Tool for Membrane Permeability Screening
Irvine, J. D., Takahashi, L., Lockhart, K., Cheong, J., Tolan, J. W., Selick, H. E., & Grove, J. R. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js9803205 · Cited by 980
Emerging Frontiers in Drug Delivery
Tibbitt, M. W., Dahlman, J. E., & Langer, R. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.5b09974 · Cited by 975
Machine learning in chemoinformatics and drug discovery
Lo, Y.-C., Rensi, S. E., Torng, W., & Altman, R. B. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.05.010 · Cited by 960
Supersaturating Drug Delivery Systems: The Answer to Solubility-Limited Oral Bioavailability?
Brouwers, J., Brewster, M. E., & Augustijns, P. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21650 · Cited by 947
Self-citationMolecular Mobility of Amorphous Pharmaceutical Solids Below Their Glass Transition Temperatures
Hancock, B. C., Shamblin, S. L., & Zografi, G. (1995) · Pharmaceutical Research · doi:10.1023/a:1016292416526 · Cited by 889
Pouton, C. W., & Porter, C. J. H. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.10.010 · Cited by 885
A new chapter in pharmaceutical manufacturing: 3D-printed drug products
Norman, J., Madurawe, R. D., Moore, C. M. V., Khan, M. A., & Khairuzzaman, A. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.03.001 · Cited by 810
Dissolution Media Simulating Conditions in the Proximal Human Gastrointestinal Tract: An Update
Jantratid, E., Janssen, N., Reppas, C., & Dressman, J. B. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9569-4 · Cited by 764
Enhanced sampling techniques in molecular dynamics simulations of biological systems
Bernardi, R. C., Melo, M. C. R., & Schulten, K. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.10.019 · Cited by 757
Polar Molecular Surface Properties Predict the Intestinal Absorption of Drugs in Humans
Palm, K., Stenberg, P., Luthman, K., & Artursson1, P. (1997) · Pharmaceutical Research · doi:10.1023/a:1012188625088 · Cited by 756
3D printing in pharmaceutics: A new tool for designing customized drug delivery systems
Goole, J., & Amighi, K. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.12.071 · Cited by 660
Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs
Vo, C. L.-N., Park, C., & Lee, B.-J. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.09.007 · Cited by 651
The influence of lead discovery strategies on the properties of drug candidates
Keserü, G. M., & Makara, G. M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2796 · Cited by 628
Hydroxypropyl Methylcellulose Acetate Succinate-Based Spray-Dried Dispersions: An Overview
Friesen, D. T., Shanker, R., Crew, M., Smithey, D. T., Curatolo, W. J., & Nightingale, J. A. S. (2008) · Molecular Pharmaceutics · doi:10.1021/mp8000793 · Cited by 610
Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging
SCHILLER, C., FRÖHLICH, C. ‐., GIESSMANN, T., SIEGMUND, W., MÖNNIKES, H., HOSTEN, N., & WEITSCHIES, W. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02683.x · Cited by 596
Hauss, D. J. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.006 · Cited by 595
Van den Mooter, G. (2012) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2011.10.002 · Cited by 577
Handbook of Pharmaceutical Salts: Properties, Selection, and Use
(2002) · Chemistry International -- Newsmagazine for IUPAC · doi:10.1515/ci.2002.24.3.20a · Cited by 532
Spray drying formulation of amorphous solid dispersions
Singh, A., & Van den Mooter, G. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.12.010 · Cited by 526
Lundquist, P., & Artursson, P. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.07.007 · Cited by 483
Lipid-Based Delivery Systems and Intestinal Lymphatic Drug Transport: A Mechanistic Update
Trevaskis, N. L., Charman, W. N., & Porter, C. J. H. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.09.007 · Cited by 442
The Future of Pharmaceutical Manufacturing Sciences
Rantanen, J., & Khinast, J. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24594 · Cited by 442
Assessment of Recent Process Analytical Technology (PAT) Trends: A Multiauthor Review
Simon, L. L., Pataki, H., Marosi, G., Meemken, F., Hungerbühler, K., Baiker, A., Tummala, S., Glennon, B., Kuentz, M., Steele, G., et al. (2015) · Organic Process Research & Development · doi:10.1021/op500261y · Cited by 439
Self-citationButler, J. M., & Dressman, J. B. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22217 · Cited by 427
50 years of oral lipid-based formulations: provenance, progress and future perspectives
Feeney, O. M., Crum, M. F., McEvoy, C. L., Trevaskis, N. L., Williams, H. D., Pouton, C. W., Charman, W. N., Bergström, C. A. S., & Porter, C. J. H. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.007 · Cited by 426
Self-citationA guide to Ussing chamber studies of mouse intestine
Clarke, L. L. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90649.2008 · Cited by 419
Berry, D. J., & Steed, J. W. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.03.003 · Cited by 406
Physical chemistry of supersaturated solutions and implications for oral absorption
Taylor, L. S., & Zhang, G. G. Z. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.03.006 · Cited by 392
The Practice of Medicinal Chemistry
(2015) · Elsevier eBooks · doi:10.1016/c2012-0-03066-9 · Cited by 383
Amorphous solid dispersions: Rational selection of a manufacturing process
Vasconcelos, T., Marques, S., das Neves, J., & Sarmento, B. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.01.012 · Cited by 380
Estimation of the aqueous solubility I: Application to organic nonelectrolytes
Jain, N., & Yalkowsky, S. H. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200102)90:2<234::aid-jps14>3.0.co;2-v · Cited by 375
VERTZONI, M., DRESSMAN, J., BUTLER, J., HEMPENSTALL, J., & REPPAS, C. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.03.002 · Cited by 358
Molecular dynamics-driven drug discovery: leaping forward with confidence
Ganesan, A., Coote, M. L., & Barakat, K. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2016.11.001 · Cited by 357
The Hydrophobic Barrier Properties of Gastrointestinal Mucus
Lichtenberger, L. M. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.003025 · Cited by 331
Lipid-based formulations for oral administration of poorly water-soluble drugs
Mu, H., Holm, R., & Müllertz, A. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.03.054 · Cited by 328
Self-citationWarren, D. B., Benameur, H., Porter, C. J. H., & Pouton, C. W. (2010) · Journal of Drug Targeting · doi:10.3109/1061186x.2010.525652 · Cited by 323
PBPK models for the prediction of in vivo performance of oral dosage forms
Kostewicz, E. S., Aarons, L., Bergstrand, M., Bolger, M. B., Galetin, A., Hatley, O., Jamei, M., Lloyd, R., Pepin, X., Rostami-Hodjegan, A., et al. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.09.008 · Cited by 315
Paulekuhn, G. S., Dressman, J. B., & Saal, C. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm701032y · Cited by 304
Cell permeability beyond the rule of 5
Matsson, P., Doak, B. C., Over, B., & Kihlberg, J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.03.013 · Cited by 297
Mahler, G. J., Shuler, M. L., & Glahn, R. P. (2009) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2008.05.006 · Cited by 287
Mucus as a barrier to lipophilic drugs
Sigurdsson, H. H., Kirch, J., & Lehr, C.-M. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.05.040 · Cited by 280
Williams, H. D., Sassene, P., Kleberg, K., Bakala-N'Goma, J.-C., Calderone, M., Jannin, V., Igonin, A., Partheil, A., Marchaud, D., Jule, E., et al. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23205 · Cited by 274
Self-citationAntunes, F., Andrade, F., Araújo, F., Ferreira, D., & Sarmento, B. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.10.003 · Cited by 269
Sarode, A. L., Sandhu, H., Shah, N., Malick, W., & Zia, H. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.12.012 · Cited by 267
3D printed medicines: A new branch of digital healthcare
Awad, A., Trenfield, S. J., Gaisford, S., & Basit, A. W. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.07.024 · Cited by 265
Is Multitask Deep Learning Practical for Pharma?
Ramsundar, B., Liu, B., Wu, Z., Verras, A., Tudor, M., Sheridan, R. P., & Pande, V. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00146 · Cited by 263
Hayeshi, R., Hilgendorf, C., Artursson, P., Augustijns, P., Brodin, B., Dehertogh, P., Fisher, K., Fossati, L., Hovenkamp, E., Korjamo, T., et al. (2008) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.08.004 · Cited by 263
Self-citationKawakami, K. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.10.009 · Cited by 259
Bergström, C. A. S., & Larsson, P. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.01.044 · Cited by 245
Self-citationRossi Sebastiano, M., Doak, B. C., Backlund, M., Poongavanam, V., Over, B., Ermondi, G., Caron, G., Matsson, P., & Kihlberg, J. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00347 · Cited by 234
Vithani, K., Goyanes, A., Jannin, V., Basit, A. W., Gaisford, S., & Boyd, B. J. (2019) · Pharmaceutical Research · doi:10.1007/s11095-018-2531-1 · Cited by 233
Self-citationStrategies for Absorption Screening in Drug Discovery and Development
Bohets, H., Annaert, P., Mannens, G., van Beijsterveldt, L., Anciaux, K., Verboven, P., Meuldermans, W., & Lavrijsen, K. (2001) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026013394886 · Cited by 230
Dahan, A., & Hoffman, A. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.01.017 · Cited by 230
Cocrystals to facilitate delivery of poorly soluble compounds beyond-rule-of-5
Kuminek, G., Cao, F., Bahia de Oliveira da Rocha, A., Gonçalves Cardoso, S., & Rodríguez-Hornedo, N. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.022 · Cited by 230
Sjöberg, Å., Lutz, M., Tannergren, C., Wingolf, C., Borde, A., & Ungell, A.-L. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.10.007 · Cited by 226
Zhang, Y., Wang, J., Bai, X., Jiang, T., Zhang, Q., & Wang, S. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200287c · Cited by 225
Béduneau, A., Tempesta, C., Fimbel, S., Pellequer, Y., Jannin, V., Demarne, F., & Lamprecht, A. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.03.017 · Cited by 224
Self-citationIonic liquids in drug delivery
Shamshina, J. L., Barber, P. S., & Rogers, R. D. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.808185 · Cited by 223
Anderberg, E. K., Lindmark, T., & Artursson, P. (1993) · Pharmaceutical Research · doi:10.1023/a:1018909210879 · Cited by 221
Gao, P., & Morozowich, W. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.1.97 · Cited by 221
STUDIES ON 5,5'-DIPHENYLHYDANTOIN (DILANTIN) IN ANIMALS AND MAN
Dill, W. A., Kazenko, A., Wolf, L. M., & Glazko, A. J. (1956) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11757-6 · Cited by 219
Phillips, D. J., Pygall, S. R., Cooper, V. B., & Mann, J. C. (2012) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2012.01523.x · Cited by 213
Biopharmaceutical classification of poorly soluble drugs with respect to “enabling formulations”
Buckley, S. T., Frank, K. J., Fricker, G., & Brandl, M. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.04.002 · Cited by 213
Self-citationPsachoulias, D., Vertzoni, M., Goumas, K., Kalioras, V., Beato, S., Butler, J., & Reppas, C. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0506-6 · Cited by 205
Miller, J. M., Beig, A., Krieg, B. J., Carr, R. A., Borchardt, T. B., Amidon, G. E., Amidon, G. L., & Dahan, A. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200181v · Cited by 204
Lindmark, T., Nikkilä, T., & Artursson, P. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12150-2 · Cited by 200
Augustijns, P., Wuyts, B., Hens, B., Annaert, P., Butler, J., & Brouwers, J. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.08.027 · Cited by 199
Self-citationDrug permeability profiling using cell-free permeation tools: overview and applications
Berben, P., Bauer-Brandl, A., Brandl, M., Faller, B., Flaten, G. E., Jacobsen, A.-C., Brouwers, J., & Augustijns, P. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.04.016 · Cited by 199
Self-citationDiffusion of Drugs in Native and Purified Gastrointestinal Mucus
Larhed, A. W., Artursson, P., Gråsjö, J., & Björk, E. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js960503w · Cited by 194
Araújo, F., & Sarmento, B. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.10.003 · Cited by 194
Markopoulos, C., Andreas, C. J., Vertzoni, M., Dressman, J., & Reppas, C. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.009 · Cited by 190
Dissolution Rate and Apparent Solubility of Poorly Soluble Drugs in Biorelevant Dissolution Media
Fagerberg, J. H., Tsinman, O., Sun, N., Tsinman, K., Avdeef, A., & Bergström, C. A. S. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100049m · Cited by 187
Self-citationComputational prediction of formulation strategies for beyond-rule-of-5 compounds
Bergström, C. A. S., Charman, W. N., & Porter, C. J. H. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.02.005 · Cited by 187
Self-citationFriedl, H., Dünnhaupt, S., Hintzen, F., Waldner, C., Parikh, S., Pearson, J. P., Wilcox, M. D., & Bernkop-Schnürch, A. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23757 · Cited by 180
Self-citationFlaten, G. E., Dhanikula, A. B., Luthman, K., & Brandl, M. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.08.007 · Cited by 180
Self-citationIonic liquids for addressing unmet needs in healthcare
Agatemor, C., Ibsen, K. N., Tanner, E. E. L., & Mitragotri, S. (2018) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10083 · Cited by 180
Buckley, S. T., Fischer, S. M., Fricker, G., & Brandl, M. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.12.007 · Cited by 179
Self-citationMasaoka, Y., Tanaka, Y., Kataoka, M., Sakuma, S., & Yamashita, S. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.06.004 · Cited by 177
Mohsin, K., Long, M. A., & Pouton, C. W. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21659 · Cited by 171
Clinical study of solid dispersions of itraconazole prepared by hot-stage extrusion
Six, K., Daems, T., de Hoon, J., Van Hecken, A., Depre, M., Bouche, M.-P., Prinsen, P., Verreck, G., Peeters, J., Brewster, M. E., et al. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2004.10.005 · Cited by 170
Poorly Soluble Marketed Drugs Display Solvation Limited Solubility
Bergström, C. A. S., Wassvik, C. M., Johansson, K., & Hubatsch, I. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0706416 · Cited by 170
Self-citationPharmaceutical excipients — quality, regulatory and biopharmaceutical considerations
Elder, D. P., Kuentz, M., & Holm, R. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.12.018 · Cited by 169
Self-citationWikman-Larhed, A., & Artursson, P. (1995) · European Journal of Pharmaceutical Sciences · doi:10.1016/0928-0987(95)00007-z · Cited by 163
N‘Goma, J.-C. B., Amara, S., Dridi, K., Jannin, V., & Carrière, F. (2012) · Therapeutic Delivery · doi:10.4155/tde.11.138 · Cited by 163
Self-citationThe influence of the 'organizational factor' on compound quality in drug discovery
Leeson, P. D., & St-Gallay, S. A. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3552 · Cited by 162
Anby, M. U., Williams, H. D., McIntosh, M. P., Benameur, H., Edwards, G. A., Pouton, C. W., & Porter, C. J. H. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300164u · Cited by 162
Intestinal in vitro and ex vivo Models to Study Host-Microbiome Interactions and Acute Stressors
Pearce, S. C., Coia, H. G., Karl, J. P., Pantoja-Feliciano, I. G., Zachos, N. C., & Racicot, K. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01584 · Cited by 162
Supersaturating Drug Delivery Systems: Fast is Not Necessarily Good Enough
Augustijns, P., & Brewster, M. E. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22750 · Cited by 161
Self-citationPhysical Stability of Salts of Weak Bases in the Solid-State
Stephenson, G. A., Aburub, A., & Woods, T. A. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22405 · Cited by 161
Sun, D. D., Wen, H., & Taylor, L. S. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2016.03.024 · Cited by 160
Vinarov, Z., Katev, V., Radeva, D., Tcholakova, S., & Denkov, N. D. (2018) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2017.1408642 · Cited by 160
Self-citationCyclodextrin nanosystems in oral drug delivery: A mini review
Adeoye, O., & Cabral-Marques, H. M. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.04.050 · Cited by 159
Cuiné, J. F., Charman, W. N., Pouton, C. W., Edwards, G. A., & Porter, C. J. H. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9194-z · Cited by 157
Rozehnal, V., Nakai, D., Hoepner, U., Fischer, T., Kamiyama, E., Takahashi, M., Yasuda, S., & Mueller, J. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.02.025 · Cited by 156
Williams, H. D., Sahbaz, Y., Ford, L., Nguyen, T., Scammells, P. J., & Porter, C. J. H. (2013) · Chemical Communications · doi:10.1039/c3cc48650h · Cited by 152
Sassene, P. J., Knopp, M. M., Hesselkilde, J. Z., Koradia, V., Larsen, A. T., Rades, T., & Müllertz, A. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22226 · Cited by 151
Self-citationLarsen, A. T., Sassene, P. J., & Müllertz, A. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.03.002 · Cited by 150
Self-citationNew biomimetic barrier Permeapad™ for efficient investigation of passive permeability of drugs
di Cagno, M., Bibi, H. A., & Bauer-Brandl, A. (2015) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.03.019 · Cited by 146
Self-citationMiller, J. M., Beig, A., Carr, R. A., Webster, G. K., & Dahan, A. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200460u · Cited by 146
Frank, K. J., Rosenblatt, K. M., Westedt, U., Hölig, P., Rosenberg, J., Mägerlein, M., Fricker, G., & Brandl, M. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.08.014 · Cited by 145
Self-citationPEG-functionalized microparticles selectively target inflamed mucosa in inflammatory bowel disease
Lautenschläger, C., Schmidt, C., Lehr, C., Fischer, D., & Stallmach, A. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.09.016 · Cited by 142
Mucus permeating carriers: formulation and characterization of highly densely charged nanoparticles
de Sousa, I. P., Steiner, C., Schmutzler, M., Wilcox, M. D., Veldhuis, G. J., Pearson, J. P., Huck, C. W., Salvenmoser, W., & Bernkop‐Schnürch, A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.12.024 · Cited by 142
Self-citationThe effects of surfactants on the dissolution profiles of poorly water-soluble acidic drugs
Park, S. H., & Choi, H. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.05.004 · Cited by 142
Cell-basedin vitromodels for predicting drug permeability
Sarmento, B. F. C. C., Andrade, F., Baptista-Silva, S., Rodrigues, F., das Neves, J., & Ferreira, D. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.673586 · Cited by 142
Williams, H. D., Anby, M. U., Sassene, P. J., Kleberg, K., N’Goma, J. B., Calderone, M., Jannin, V., Igonin, A., Partheil, A., Marchaud, D., et al. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300331z · Cited by 142
Self-citationYuan, X., Xiang, T., Anderson, B. D., & Munson, E. J. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00705 · Cited by 141
Self-emulsifying peptide drug delivery systems: How to make them highly mucus permeating
Griesser, J., Hetényi, G., Kadas, H., Demarne, F., Jannin, V., & Bernkop‐Schnürch, A. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.01.018 · Cited by 141
Self-citationChen, J., Ormes, J. D., Higgins, J. D., & Taylor, L. S. (2015) · Molecular Pharmaceutics · doi:10.1021/mp5006245 · Cited by 138
Westerhout, J., van de Steeg, E., Grossouw, D., Zeijdner, E. E., Krul, C. A. M., Verwei, M., & Wortelboer, H. M. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.07.003 · Cited by 136
Effect of pH and Comedication on Gastrointestinal Absorption of Posaconazole
Walravens, J., Brouwers, J., Spriet, I., Tack, J. F., Annaert, P., & Augustijns, P. (2011) · Clinical Pharmacokinetics · doi:10.2165/11592630-000000000-00000 · Cited by 131
Self-citationKoziolek, M., Grimm, M. F., Garbacz, G., Kühn, J., & Weitschies, W. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500022u · Cited by 130
Supersaturating drug delivery systems: The potential of co-amorphous drug formulations
Laitinen, R., Löbmann, K., Grohganz, H., Priemel, P. A., Strachan, C. J., & Rades, T. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.08.123 · Cited by 127
Griffin, B. T., Kuentz, M., Vertzoni, M., Kostewicz, E. S., Fei, Y., Faisal, W., Stillhart, C., O’Driscoll, C. M., Reppas, C., & Dressman, J. B. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.10.016 · Cited by 126
Self-citationFernandez, S., Jannin, V., Rodier, J.-D., Ritter, N., Mahler, B., & Carrière, F. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.02.009 · Cited by 126
Self-citationMolecular Characteristics for Solid-State Limited Solubility
Wassvik, C. M., Holmén, A. G., Draheim, R., Artursson, P., & Bergström, C. A. S. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701587d · Cited by 125
Self-citationStewart, A. M., Grass, M. E., Brodeur, T. J., Goodwin, A. K., Morgen, M. M., Friesen, D. T., & Vodak, D. T. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00338 · Cited by 125
Muller, C. R., Leithner, K., Hauptstein, S., Hintzen, F., Salvenmoser, W., & Bernkop‐Schnürch, A. (2012) · Journal of Nanoparticle Research · doi:10.1007/s11051-012-1353-z · Cited by 120
Self-citationSupersaturation and Precipitation of Posaconazole Upon Entry in the Upper Small Intestine in Humans
Hens, B., Brouwers, J., Corsetti, M., & Augustijns, P. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24690 · Cited by 116
Self-citationTurco, L., Catone, T., Caloni, F., Consiglio, E. D., Testai, E., & Stammati, A. P. (2010) · Toxicology in Vitro · doi:10.1016/j.tiv.2010.08.009 · Cited by 116
Williams, H. D., Sassene, P. J., Kleberg, K., Calderone, M., Igonin, A., Jule, E., Vertommen, J., Blundell, R., Benameur, H., Müllertz, A., et al. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1038-z · Cited by 113
Self-citationŠibík, J., & Zeitler, J. A. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.12.021 · Cited by 113
Biorelevant Dissolution Media Simulating the Proximal Human Gastrointestinal Tract: An Update
Jantratid, E., & Dressman, J. (2009) · Dissolution Technologies · doi:10.14227/dt160309p21 · Cited by 112
Hens, B., Corsetti, M., Spiller, R. E., Marciani, L., Vanuytsel, T., Tack, J. F., Talattof, A., Amidon, G. L., Koziolek, M., Weitschies, W., et al. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.11.063 · Cited by 111
Self-citationTransforming Computational Drug Discovery with Machine Learning and AI
Smith, J. S., Roitberg, A. E., & Isayev, O. (2018) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.8b00437 · Cited by 110
Bhat, P. A., Dar, A. A., & Rather, G. M. (2008) · Journal of Chemical & Engineering Data · doi:10.1021/je700659g · Cited by 109
Löbenberg, R., Krämer, J., Shah, V. P., Amidon, G. L., & Dressman, J. (2000) · Pharmaceutical Research · doi:10.1023/a:1007529020774 · Cited by 108
The role of mucus in cell-based models used to screen mucosal drug delivery
Lechanteur, A., das Neves, J., & Sarmento, B. F. C. C. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.07.019 · Cited by 106
Li, P., Tan, A., Prestidge, C. A., Nielsen, H. M., & Müllertz, A. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.10.039 · Cited by 105
Self-citationBeloqui, A., Brayden, D. J., Artursson, P., Véronique Préat, A., & Rieux, A. D. (2017) · Nature Protocols · doi:10.1038/nprot.2017.041 · Cited by 105
Kataoka, M., Masaoka, Y., Sakuma, S., & Yamashita, S. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20691 · Cited by 103
Dependence of Molecular Properties on Proteomic Family for Marketed Oral Drugs
Vieth, M., & Sutherland, J. J. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0603825 · Cited by 103
The role of polymers in oral bioavailability enhancement; a review
Liu, H., Taylor, L. S., & Edgar, K. J. (2015) · Polymer · doi:10.1016/j.polymer.2015.09.026 · Cited by 101
Hens, B., Brouwers, J., Corsetti, M., & Augustijns, P. (2015) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.05.023 · Cited by 100
Self-citationFernandez, S., Chevrier, S., Ritter, N., Mahler, B., Demarne, F., Carrière, F., & Jannin, V. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9906-2 · Cited by 100
Self-citationPathak, S. M., Ruff, A., Kostewicz, E. S., Patel, N. K., Turner, D. B., & Jamei, M. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00406 · Cited by 100
Lipolysis of the semi-solid self-emulsifying excipient Gelucire® 44/14 by digestive lipases
Fernandez, S., Rodier, J.-D., Ritter, N., Mahler, B., Demarne, F., Carrière, F., & Jannin, V. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2008.05.006 · Cited by 99
Self-citationBrouwers, J., Tack, J. F., Lammert, F., & Augustijns, P. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20553 · Cited by 99
Self-citationLarsen, A. T., Ohlsson, A. G., Polentarutti, B. I., Barker, R. A., Phillips, A. R., Abu-Rmaileh, R., Dickinson, P. A., Abrahamsson, B., Østergaard, J., & Müllertz, A. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.11.004 · Cited by 98
Self-citationGrzybowska, K., Capaccioli, S., & Paluch, M. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.12.008 · Cited by 98
Capolino, P., Guérin, C., Paume, J., Giallo, J., Ballester, J.-M., Cavalier, J., & Carrière, F. (2011) · Food Digestion · doi:10.1007/s13228-011-0014-5 · Cited by 96
Xiang, T., & Anderson, B. D. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23353 · Cited by 95
Caco-2 Cell Conditions Enabling Studies of Drug Absorption from Digestible Lipid-Based Formulations
Keemink, J., & Bergström, C. A. S. (2018) · Pharmaceutical Research · doi:10.1007/s11095-017-2327-8 · Cited by 94
Self-citationMethodology of oral formulation selection in the pharmaceutical industry
Kuentz, M., Holm, R., & Elder, D. P. (2015) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.12.008 · Cited by 93
Self-citationDengale, S. J., Hussen, S. S., Krishna, B., Musmade, P. B., Shenoy, G. G., & Bhat, K. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.12.025 · Cited by 92
A Refined Developability Classification System
Rosenberger, J., Butler, J., & Dressman, J. (2018) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2018.03.030 · Cited by 92
Supersaturated polymeric micelles for oral cyclosporine A delivery
Yu, H., Xia, D., Zhu, Q., Zhu, C., Chen, D., & Gan, Y. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.08.003 · Cited by 90
Oral bioavailability enhancement through supersaturation: an update and meta-analysis
Fong, S. Y. K., Bauer‐Brandl, A., & Brandl, M. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1218465 · Cited by 89
Self-citationUse of biorelevant dissolution and PBPK modeling to predict oral drug absorption
Kaur, N., Narang, A. S., & Bansal, A. K. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.05.024 · Cited by 86
Prediction of dissolution–absorption relationships from a dissolution/Caco-2 system
Ginski, M. J. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00330-5 · Cited by 85
Microfluidics: a transformational tool for nanomedicine development and production
Garg, S., Heuck, G., Ip, S. Y., & Ramsay, E. (2016) · Journal of drug targeting · doi:10.1080/1061186x.2016.1198354 · Cited by 83
Lipolysis-Permeation Setup for Simultaneous Study of Digestion and Absorption in Vitro
Keemink, J., Mårtensson, E., & Bergström, C. A. S. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00811 · Cited by 82 · cited 1×
“Solutions to the latter limitation will be discussed in the following chapter as promising results were obtained by Bergström and coworkers very recently (Keemink and Bergström, 2018; Keemink et al., 2019).”
BackgroundHens, B., Pathak, S. M., Mitra, A., Patel, N. K., Liu, B., Patel, S. R., Jamei, M., Brouwers, J., Augustijns, P., & Turner, D. B. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00396 · Cited by 80
Self-citationHédoux, A. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.11.021 · Cited by 79
Vertzoni, M., Markopoulos, C., Symillides, M., Goumas, C., Imanidis, G., & Reppas, C. I. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200479f · Cited by 78
Yeap, Y. Y., Trevaskis, N. L., & Porter, C. J. H. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1104-6 · Cited by 77
Improving Ibuprofen solubility by surfactant-facilitated self-assembly into mixed micelles
Stoyanova, K., Vinarov, Z., & Tcholakova, S. S. (2016) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2016.10.011 · Cited by 77
Self-citationDrug permeability across a phospholipid vesicle-based barrier
Flaten, G. E., Bunjes, H., Luthman, K., & Brandl, M. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.03.008 · Cited by 76
Self-citationN’Goma, J. B., Williams, H. D., Sassene, P. J., Kleberg, K., Calderone, M., Jannin, V., Igonin, A., Partheil, A., Marchaud, D., Jule, E., et al. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1532-y · Cited by 76
Self-citationKlein, S., Stein, J. M., & Dressman, J. (2005) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357056172 · Cited by 76
Cell-based in vitro models for intestinal permeability studies
Pereira, C., Costa, J. R., Sarmento, B. F. C. C., & Araújo, F. (2015) · Elsevier eBooks · doi:10.1016/b978-0-08-100094-6.00005-5 · Cited by 74
Αbeele, J. V. D., Brouwers, J., Mattheus, R., Tack, J. F., & Augustijns, P. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24647 · Cited by 73
Self-citationMolecular Aspects of Mucoadhesive Carrier Development for Drug Delivery and Improved Absorption
Peppas, N. A., Thomas, J. B., & McGinty, J. (2008) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/156856208x393464 · Cited by 73
Molecular Dynamics Simulation of Amorphous Indomethacin
Xiang, T., & Anderson, B. D. (2012) · Molecular Pharmaceutics · doi:10.1021/mp3000698 · Cited by 72
Quan, G., Niu, B., Singh, V., Zhou, Y., Wu, C., Pan, X., & Wu, C. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s149717 · Cited by 72
Mathias, N. R., Xu, Y., Patel, D., Grass, M., Caldwell, B., Jager, C., Mullin, J., Hansen, L., Crison, J. R., Saari, A., et al. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400426f · Cited by 71
Khadra, I., Zhou, Z., Dunn, C., WILSON, C. G., & Halbert, G. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.10.019 · Cited by 70
Sassene, P. J., Kleberg, K., Williams, H. D., N’Goma, J. B., Carrière, F., Calderone, M., Jannin, V., Igonin, A., Partheil, A., Marchaud, D., et al. (2014) · The AAPS Journal · doi:10.1208/s12248-014-9672-x · Cited by 70
Self-citationComputational Prediction of Drug Solubility in Fasted Simulated and Aspirated Human Intestinal Fluid
Fagerberg, J. H., Karlsson, Ε., Ulander, J., Hanisch, G., & Bergström, C. A. S. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1487-z · Cited by 70
Self-citationLadas, S. D., Isaacs, P. E. T., Murphy, G. M., & Sladen, G. E. (1984) · Gut · doi:10.1136/gut.25.4.405 · Cited by 70
Brandl, M., Frank, K., Westedt, et al. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s36571 · Cited by 69
Self-citationStewart, A. M., Grass, M. E., Mudie, D. M., Morgen, M. M., Friesen, D. T., & Vodak, D. T. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00121 · Cited by 69
Bibi, H. A., Holm, R., & Bauer-Brandl, A. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.05.001 · Cited by 68 · cited 3×
“solvents, and biomimetic media and even withstands lipolysis conditions used for SEDDS and SNEDDS (Bibi et al., 2017; Flaten et al., 2006a).”
MethodInfluentialSelf-citationDynamic dissolution-/permeation-testing of nano- and microparticle formulations of fenofibrate
Sironi, D., Rosenberg, J., Bauer‐Brandl, A., & Brandl, M. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.09.001 · Cited by 67
Self-citationBarbieri, S., Buttini, F., Rossi, A., Bettini, R., Colombo, P., Ponchel, G., Sonvico, F., & Colombo, G. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.06.021 · Cited by 66
Formulation strategies for solid oral dosage form using 3D printing technology: A mini-review
Khatri, P., Shah, M. K., & Vora, N. (2018) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2018.05.009 · Cited by 66
Jannin, V., Chevrier, S., Michenaud, M., Dumont, C., Belotti, S., Chavant, Y., & Demarne, F. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.09.009 · Cited by 65
Self-citationCrystalline mesophases: Structure, mobility, and pharmaceutical properties
Shalaev, E., Ke, W., Shamblin, S. L., Krzyzaniak, J. F., & Descamps, M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.002 · Cited by 65
Suys, E. J. A., Chalmers, D. K., Pouton, C. W., & Porter, C. J. H. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00206 · Cited by 65
Holm, R. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.01.009 · Cited by 65
Is 3D Printing of Pharmaceuticals a Disruptor or Enabler?
Liang, K., Brambilla, D., & Leroux, J. (2018) · Advanced Materials · doi:10.1002/adma.201805680 · Cited by 64
Koenigsknecht, M. J., Baker, J. R., Wen, B., et al. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00425 · Cited by 63
Rethinking carbamazepine oral delivery using polymer-lipid hybrid nanoparticles
da Ana, R., Mendes, M., Sousa, J., Pais, A. A. C. C., Falcão, A. C., Fortuna, A. C., & Vitorino, C. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.11.028 · Cited by 63
Cited by
Advances in Oral Drug Delivery
Alqahtani, M. S., Kazi, M., Alsenaidy, M. A., & Ahmad, M. Z. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.618411 · Cited by 876
Crystal Engineering of Pharmaceutical Cocrystals in the Discovery and Development of Improved Drugs
Bolla, G., Sarma, B., & Nangia, A. K. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00987 · Cited by 597
Vinarov, Z., Abdallah, M., Agundez, J. A. G., Allegaert, K., Basit, A. W., Braeckmans, M., Ceulemans, J., Corsetti, M., Griffin, B. T., Grimm, M., et al. (2021) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2021.105812 · Cited by 359
Self-citationMachine learning directed drug formulation development
Bannigan, P., Aldeghi, M., Bao, Z., Häse, F., Aspuru-Guzik, A., & Allen, C. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.016 · Cited by 335
Buya, A. B., Beloqui, A., Memvanga, P. B., & Préat, V. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121194 · Cited by 301
Self-citation
Metadata
- Authors
- Boyd, B. J., Bergström, C. A. S., Vinarov, Z., Kuentz, M., Brouwers, J., Augustijns, P., Brandl, M., Bernkop-Schnürch, A., Shrestha, N., Préat, V., Müllertz, A., Bauer-Brandl, A., & Jannin, V.
- Venue
- European Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2019-09
- Volume
- 137
- Pages
- 104967
- ISSN
- 0928-0987 (ISSN-L)
- OpenAlex
- W2955461563
- Cited by
- 367
- References
- 274
- FWCI
- 17.47
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.